243 related articles for article (PubMed ID: 26253468)
21. Induction of protective and therapeutic antitumor immunity by a DNA vaccine with C3d as a molecular adjuvant.
Xu GL; Zhang KQ; Guo B; Zhao TT; Yang F; Jiang M; Wang QH; Shang YH; Wu YZ
Vaccine; 2010 Oct; 28(44):7221-7. PubMed ID: 20800113
[TBL] [Abstract][Full Text] [Related]
22. [Construction of a replicative anti-tumor DNA vaccine PSCK-2PFcGB and its expression in vivo and in vitro].
Zhang L; Yan JQ; Wang Y; Xiao Y; Gao K; Dong JK; Wang B; Yu JY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):937-42. PubMed ID: 21690041
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tüting T
Cancer Res; 2006 May; 66(10):5427-35. PubMed ID: 16707471
[TBL] [Abstract][Full Text] [Related]
24. A combination of flk1-based DNA vaccine and an immunomodulatory gene (IL-12) in the treatment of murine cancer.
Keke F; Hongyang Z; Hui Q; Jixiao L; Jian C
Cancer Biother Radiopharm; 2004 Oct; 19(5):649-57. PubMed ID: 15650458
[TBL] [Abstract][Full Text] [Related]
25. Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide.
Chen R; Wang S; Yao Y; Zhou Y; Zhang C; Fang J; Zhang D; Zhang L; Pan J
Oncol Rep; 2015 May; 33(5):2269-76. PubMed ID: 25739076
[TBL] [Abstract][Full Text] [Related]
26. Enhanced potency of replicon vaccine using one vector to simultaneously co-express antigen and interleukin-4 molecular adjuvant.
Ma Y; An HJ; Wei XQ; Xu Q; Yu YZ; Sun ZW
Hum Vaccin Immunother; 2013 Feb; 9(2):242-9. PubMed ID: 23291932
[TBL] [Abstract][Full Text] [Related]
27. Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified Xenopus RHAMM.
Yang HS; Zhang DM; Deng HX; Peng F; Wei YQ
Cancer Sci; 2010 Apr; 101(4):862-8. PubMed ID: 20704574
[TBL] [Abstract][Full Text] [Related]
28. A suicidal DNA vaccine expressing the fusion protein of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in mice.
Wang Y; Yue X; Jin H; Liu G; Pan L; Wang G; Guo H; Li G; Li Y
J Virol Methods; 2015 Dec; 225():35-40. PubMed ID: 26343487
[TBL] [Abstract][Full Text] [Related]
29. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma.
Lladser A; Ljungberg K; Tufvesson H; Tazzari M; Roos AK; Quest AF; Kiessling R
Cancer Immunol Immunother; 2010 Jan; 59(1):81-92. PubMed ID: 19526360
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.
Jarosz M; Jazowiecka-Rakus J; Cichoń T; Głowala-Kosińska M; Smolarczyk R; Smagur A; Malina S; Sochanik A; Szala S
Gene Ther; 2013 Mar; 20(3):262-73. PubMed ID: 22495576
[TBL] [Abstract][Full Text] [Related]
31. The fusion protein of HSP65 with tandem repeats of beta-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma.
Xiangbing H; Yankai Z; Ming L; Yong L; Yu Z; Huiyong Z; Yingying C; Jing H; Yun X; Liang J; Rongyue C; Jingjing L
Int Immunopharmacol; 2010 Feb; 10(2):230-8. PubMed ID: 19913113
[TBL] [Abstract][Full Text] [Related]
32. Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12.
Riezebos-Brilman A; Regts J; Chen M; Wilschut J; Daemen T
Vaccine; 2009 Jan; 27(5):701-7. PubMed ID: 19041356
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.
Kawakami K; Terabe M; Kawakami M; Berzofsky JA; Puri RK
Cancer Res; 2006 Apr; 66(8):4434-42. PubMed ID: 16618770
[TBL] [Abstract][Full Text] [Related]
34. PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization.
Rekoske BT; Smith HA; Olson BM; Maricque BB; McNeel DG
Cancer Immunol Res; 2015 Aug; 3(8):946-55. PubMed ID: 26041735
[TBL] [Abstract][Full Text] [Related]
35. Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines.
Miguel A; Herrero MJ; Sendra L; Botella R; Algás R; Sánchez M; Aliño SF
Cancer Gene Ther; 2013 Oct; 20(10):576-81. PubMed ID: 23969885
[TBL] [Abstract][Full Text] [Related]
36. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
Yu YZ; Liu S; Ma Y; Gong ZW; Wang S; Sun ZW
Hum Vaccin Immunother; 2014; 10(7):1874-9. PubMed ID: 25424795
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
Wang HC; An HJ; Yu YZ; Xu Q
Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
[TBL] [Abstract][Full Text] [Related]
38. [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
Jiao JG; Zhang YD; Li YN
Ai Zheng; 2005 Oct; 24(10):1179-83. PubMed ID: 16219129
[TBL] [Abstract][Full Text] [Related]
39. MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model.
Liu C; Xie Y; Sun B; Geng F; Zhang F; Guo Q; Wu H; Yu B; Wu J; Yu X; Kong W; Zhang H
Scand J Immunol; 2018 Feb; 87(2):63-72. PubMed ID: 29193199
[TBL] [Abstract][Full Text] [Related]
40. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
Rittich S; Duskova M; Mackova J; Pokorna D; Jinoch P; Smahel M
Oncol Rep; 2005 Feb; 13(2):311-7. PubMed ID: 15643517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
